The drug as well as the vaccines will be given on a priority basis according to the number of cases and their evaluation.The vaccination of health professionals is also included in the plan
All procedures for the importation in Cyprus of the drug tecovirimat against the monkey blessing[/B] have been completed, however the European Commission considers that Cyprus does not, so far, fall within the countries that should be given priority for the import of this drug. This is according to the Communication Advisor of the Minister of Health Constantinos Athanasiou.
In a statement to the Cyprus[/B] Times, Mr. Athanasiou said that "the drugs as well as the vaccines will be given according to the priority of the number of cases and their evaluation, noting that the formulations are used in-hospital for severely ill patients."
Asked when exactly the formulation is expected on the island, Mr. Athanasiou explained that "in some countries its distribution has already started, but for Cyprus its introduction is subject to the decisions of the European Commission and when the mass distribution of the drug will start in other EU countries."
[/B]
Meanwhile, Mr. Athanasiou noted that "in addition to close contacts of the cases, it is planned to vaccinate health professionals if and when they express interest."
And he pointed out that Cyprus is among the first countries to receive the vaccines following planning by the Ministry of Health.
Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times
Source